Literature DB >> 20395978

Selective thinning of the perifoveal inner retina as an early sign of hydroxychloroquine retinal toxicity.

S Pasadhika1, G A Fishman, D Choi, M Shahidi.   

Abstract

PURPOSE: To evaluate macular thickness profiles using spectral-domain optical coherence tomography (SDOCT) and image segmentation in patients with chronic exposure to hydroxychloroquine.
METHODS: This study included eight patients with chronic exposure to hydroxychloroquine (group 1) and eight controls (group 2). Group 1 patients had no clinically evident retinal toxicity. All subjects underwent SDOCT imaging of the macula. An image segmentation technique was used to measure thickness of six retinal layers at 200 microm intervals. A mixed-effects model was used for multivariate analysis.
RESULTS: By measuring total retinal thickness either at the central macular (2800 microm in diameter), the perifoveal region 1200-microm-width ring surrounding the central macula), or the overall macular area (5200 microm in diameter), there were no significant differences in the thickness between groups 1 and 2. On an image segmentation analysis, selective thinning of the inner plexiform+ganglion cell layers (P=0.021) was observed only in the perifoveal area of the patients in group 1 compared with that of group 2 by using the mixed-effects model analysis.
CONCLUSION: Our study results suggest that chronic exposure to hydroxychloroquine is associated with thinning of the perifoveal inner retinal layers, especially in the ganglion cell and inner plexiform layers, even in the absence of functional or structural clinical changes involving the photoreceptor or retinal pigment epithelial cell layers. This may be a contributing factor as the reason most patients who have early detectable signs of drug toxicity present with paracentral or pericentral scotomas.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395978      PMCID: PMC3711255          DOI: 10.1038/eye.2010.21

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  19 in total

1.  Incidence of hydroxychloroquine retinopathy in 1,207 patients in a large multicenter outpatient practice.

Authors:  G D Levy; S J Munz; J Paschal; H B Cohen; K J Pince; T Peterson
Journal:  Arthritis Rheum       Date:  1997-08

2.  Chloroquine toxicity in the human eye. Histopathologic observations by electron microscopy.

Authors:  M S Ramsey; B S Fine
Journal:  Am J Ophthalmol       Date:  1972-02       Impact factor: 5.258

Review 3.  Chloroquine ocular toxicity.

Authors:  H N Bernstein
Journal:  Surv Ophthalmol       Date:  1967-10       Impact factor: 6.048

Review 4.  Hydroxychloroquine treatment of rheumatoid arthritis.

Authors:  R I Rynes
Journal:  Am J Med       Date:  1988-10-14       Impact factor: 4.965

5.  Chloroquine retinopathy in the rhesus monkey.

Authors:  A R Rosenthal; H Kolb; D Bergsma; D Huxsoll; J L Hopkins
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-12       Impact factor: 4.799

Review 6.  The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: a critical review.

Authors:  D J Wallace
Journal:  Lupus       Date:  1996-06       Impact factor: 2.911

7.  Multifocal electroretinography evaluation for early detection of retinal dysfunction in patients taking hydroxychloroquine.

Authors:  Philip J Penrose; Radouil T Tzekov; Erich E Sutter; Arthur D Fu; Arthur W Allen; Wayne E Fung; Karen W Oxford
Journal:  Retina       Date:  2003-08       Impact factor: 4.256

8.  Effects of long-term chloroquine exposure on the phospholipid metabolism in retina and pigment epithelium of the mouse.

Authors:  A Hallberg; P Naeser; A Andersson
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-04

9.  The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Authors:  Ioannis Mavrikakis; Petros P Sfikakis; Emmanouil Mavrikakis; Kostantinos Rougas; Athanasios Nikolaou; Charalambos Kostopoulos; Myron Mavrikakis
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

10.  Long-term course of antimalarial maculopathy after cessation of treatment.

Authors:  M Easterbrook
Journal:  Can J Ophthalmol       Date:  1992-08       Impact factor: 1.882

View more
  19 in total

1.  Macular ganglion cell-inner plexiform layer thickness for detection of early retinal toxicity of hydroxychloroquine.

Authors:  Emrah Kan; Konuralp Yakar; Mehmet Derya Demirag; Mustafa Gok
Journal:  Int Ophthalmol       Date:  2017-07-10       Impact factor: 2.031

2.  Localization of damage in progressive hydroxychloroquine retinopathy on and off the drug: inner versus outer retina, parafovea versus peripheral fovea.

Authors:  Luis de Sisternes; Julia Hu; Daniel L Rubin; Michael F Marmor
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-05       Impact factor: 4.799

3.  A possible early sign of hydroxychloroquine macular toxicity.

Authors:  Livia M Brandao; Anja M Palmowski-Wolfe
Journal:  Doc Ophthalmol       Date:  2016-01-20       Impact factor: 2.379

4.  Evaluation of photoreceptor outer segment length in hydroxychloroquine users.

Authors:  Akin Cakir; Şeyma Gulcenur Ozturan; Dilan Yildiz; Burak Erden; Selim Bolukbasi; Ethem Koray Tascilar; Müyesser Nergiz Yanmaz; Mustafa Nuri Elcioglu
Journal:  Eye (Lond)       Date:  2019-04-01       Impact factor: 3.775

5.  Spectral domain optical coherence tomography as an effective screening test for hydroxychloroquine retinopathy (the "flying saucer" sign).

Authors:  Eric Chen; David M Brown; Matthew S Benz; Richard H Fish; Tien P Wong; Rosa Y Kim; James C Major
Journal:  Clin Ophthalmol       Date:  2010-10-21

6.  Plasma homocysteine and macular thickness in older adults-the Rugao Longevity and Aging Study.

Authors:  Hui Zhang; Hangqi Shen; Wei Gong; Xuehui Sun; Xiaoyan Jiang; Jiucun Wang; Li Jin; Xun Xu; Dawei Luo; Xiaofeng Wang
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 4.456

7.  A New Objective Parameter in Hydroxychloroquine-Induced Retinal Toxicity Screening Test: Macular Retinal Ganglion Cell-Inner Plexiform Layer Thickness.

Authors:  Mehmet Bulut; Muhammet Kazım Erol; Devrim Toslak; Melih Akidan; Ebru Kaya Başar; Hasan Fatih Çay
Journal:  Arch Rheumatol       Date:  2017-10-16       Impact factor: 1.472

8.  Spectral domain optical coherence tomography for early detection of retinal alterations in patients using hydroxychloroquine.

Authors:  Yigit Ulviye; Tugcu Betul; Tarakcioglu Hatice Nur; Celik Selda
Journal:  Indian J Ophthalmol       Date:  2013-04       Impact factor: 1.848

9.  Spectral-Domain Optical Coherence Tomography of Preclinical Chloroquine Maculopathy in Egyptian Rheumatoid Arthritis Patients.

Authors:  Riham S H M Allam; Mai N Abd-Elmohsen; Mohamed M Khafagy; Karim A Raafat; Sherif M Sheta
Journal:  J Ophthalmol       Date:  2015-08-02       Impact factor: 1.909

Review 10.  Hydroxychloroquine retinopathy: A review of imaging.

Authors:  Hemang K Pandya; Mark Robinson; Nawajes Mandal; Vinay A Shah
Journal:  Indian J Ophthalmol       Date:  2015-07       Impact factor: 1.848

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.